The project BlooDe (Blood Device)
The project BlooDe (Blood Device) aim to reproduce the platelets adherence and aggregation process on a collagen-like recombinant protein coated surface, within a microfluidic device. It will enable to better understand and quantify platelets and von Willebrand factor activities, and to study the interactions in play.
The project BlooDe is financially supported by the European Union (European Regional Development Fund) and the Swiss Confederation as part of the European Territorial Cooperation program INTERREG V A France-Switzerland 2014-2020.
The project is led by the Université de Franch-Comté (UFC) and the University of Geneva (UNIGE). The Établissement Français du Sang bourgogne franche-Comté (EFS) and the company Diagnoswiss are its partners.
NVH Medicinal, the Geneva University Hospitals (HUG), the Centre Hôpitalier Universitaire de Dijon (CHU Dijon) et the National Center for Scientific Research (CNRS).
